2. Academic Validation
  3. Optimization of the Central α-Amino Acid in Cystobactamids to the Broad-Spectrum, Resistance-Breaking Antibiotic CN-CC-861

Optimization of the Central α-Amino Acid in Cystobactamids to the Broad-Spectrum, Resistance-Breaking Antibiotic CN-CC-861

  • J Med Chem. 2024 Oct 10;67(19):17162-17190. doi: 10.1021/acs.jmedchem.4c00927.
Daniel Kohnhäuser 1,  Tim Seedorf 2,  Katarina Cirnski 3 4,  Dominik Heimann 1,  Janetta Coetzee 3 4,  Sylvie Sordello 5,  Jana Richter 1,  Moritz Stappert 1,  Jean-Francois Sabuco 5,  David Corbett 5,  Eric Bacqué 5,  Katharina Rox 1 4,  Jennifer Herrmann 3 4,  Aurelie Vassort 5,  Rolf Müller 3 4,  Andreas Kirschning 2 6,  Mark Brönstrup 1 2 4
Affiliations

Affiliations

  • 1 Department of Chemical Biology, Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany.
  • 2 Institute of Organic Chemistry and Biomolecular Drug Research Centre (BMWZ), Leibniz University Hannover, Schneiderberg 1B, 30167 Hannover, Germany.
  • 3 Microbial Natural Products, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Department of Pharmacy at Saarland University, Campus Building E8.1, 66123 Saarbrücken, Germany.
  • 4 German Center for Infection Research (DZIF), Site Hannover-Braunschweig, Inhoffenstraße 7, 38124 Braunschweig, Germany.
  • 5 Evotec ID, 1541 Avenue Marcel Merieux, 69289 Marcy l'Etoile, France.
  • 6 Uppsala Biomedical Center (BMC), Uppsala University, Husargatan 3, 752 37 Uppsala, Sweden.
PMID: 39303218 DOI: 10.1021/acs.jmedchem.4c00927
Abstract

Cystobactamids have a unique oligoarylamide structure and exhibit broad-spectrum activity against Gram-negative and Gram-positive bacteria. In this study, the central α-amino acid of the cystobactamid scaffold was modified to address the relevance of stereochemistry, hydrogen bonding and polarity by 33 derivatives. As demonstrated by three matched molecular pairs, l-amino acids were preferred over d-amino acids. A rigidification to a six-membered system stabilized the bioactive conformation for the on-target Escherichia coli gyrase, but did not improve antimicrobial activity. Compound CN-CC-861, carrying a propargyl side chain, had more than 16-fold lower minimal inhibitory concentration (MIC) values against Enterococcus faecalis, Staphylococci and Acinetobacter strains, compared to known analogues. Moreover, CN-CC-861 retained activity against multidrug-resistant enterococci, displayed strong bactericidal activity, moderate-low frequencies of resistance and in vivo efficacy in a neutropenic thigh Infection model with E. coli. Overall, the findings will guide the design of new promising structures with higher activities and broader spectrum.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z